Status:
UNKNOWN
Clinical Study - ES 900 - 2020-1
Lead Sponsor:
Haag-Streit AG
Collaborating Sponsors:
Aravind Eye Hospitals, India
Conditions:
Cataract
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
EYESTAR 900 is a device developed by Haag-Streit which utilises 3D OCT for quantitative measurements of the geometry of the entire eye, including ocular biometry and corneal topography. It is the most...
Detailed Description
The EYESTAR 900 is a non-contact device for measuring the human eye, consisting of a swept source OCT sub-unit (OCT: optical coherence tomography, a measurement method to acquire tomographic images by...
Eligibility Criteria
Inclusion
- voluntary participation
- informed consent
- 35 years of age or older
Exclusion
- ineligibility for cataract surgery for any reason, e.g., aphakia
- Disqualifying pathologies:
- keratoconus
- corneal astigmatism of more than 3.5 D
- history of recurrent inflammation or infection of the eye
- Disqualifying corneal conditions:
- comorbidities,
- deformations,
- lesions, or
- scarring of the cornea
- acute inflammation or infection of the eye
- Disqualifying treatments:
- previous refractive surgeries, including PRK and LASIK
- previous corneal surgeries
- previous corneal transplants
- previous intraocular surgeries
- Disqualifying outcomes:
- failed IOL implantation into the capsular bag
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05304182
Start Date
July 1 2022
End Date
February 28 2024
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aravind Eye Hospitals
Chennai, Tamil Nadu, India, 600077